- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05432037
Urdu Version of Fear Avoidance Belief Questionnaire: Reliability and Validity Study
Evaluation of Cultural Adaptation and Psychometric Properties of Urdu Version of Fear Avoidance Belief Questionnaire
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
Punjab
-
Faisalabad, Punjab, Pakistan, 38000
- Recruiting
- Ripah International University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients or the ones next to them who gave informed consent
- Participants with complain of low back pain for more than 3 months.
- Age at least above 18 years.
Exclusion Criteria:
- Inability to understand or follow the instructions of the Fear Avoidance Belief Questionnaire.
- Any musculoskeletal pathologies
- Suffering from any cardiovascular pathologies
- Any history of tumor and cancer
- Any history of fracture
- Any histories of infections
- Any history of neurological disorders
- Having any spinal deformity
Study Plan
How is the study designed?
Design Details
- Observational Models: Ecologic or Community
- Time Perspectives: Cross-Sectional
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Fear Avoidance Belief Questionnaire
Time Frame: 1st day
|
The fear avoidance belief questionnaire is a standardized clinical assessment tool to investigate patients work and activity specific fear-avoidance beliefs and physical disability related to work.
The Fear Avoidance Belief Questionnaire consists of 2 sub-scales.
The Physical Activity sub-scale and The Work sub-scale.
|
1st day
|
Hospital Anxiety and Depression scale
Time Frame: 1st day
|
It is the scale used for evaluation of anxiety and depression symptoms related to disease. The Hospital Anxiety and Depression scale is the objective assessment of disease related anxiety and depression symptoms based on 14 items. 7 questions for each depression and anxiety sub-scales. Scoring ranges from 0-3. Total scores are from 0-21. Normal or no anxiety scores from 0-7, 8-10 mild to moderate anxiety, 11-21 moderate to severe anxiety. |
1st day
|
Ronald Morris Questionnaire
Time Frame: 1st day
|
Ronald Morris Questionnaire is the scale used for evaluation of level of disability among patients of back pain.
Ronald Morris questionnaire is a self-administrated disability measurement based on 24 items.
Higher level of disability is represented by greater score on 24-points scale.
|
1st day
|
Quebec Pain Rating Scale
Time Frame: 1st day
|
The Quebec Back Pain Disability Scale is a 20-item self-administered device designed to assess the level of practical disability in people with low back pain.
The scale is a reliable and accurate measure used to monitor the progress of individual patients participating in treatment or rehabilitation programs.
|
1st day
|
Visual Analog Scale
Time Frame: 1st day
|
Scores of Visual Analog Scale are based on self-reported measures of symbols that are recorded with a length of 10 as well as a written mark placed in one place.
The centimetre line that represents the continuity between the two ends of the scale - from "no pain" on the left end of the scale (0 cm) and the "worst pain" on the right end of the scale (10 cm).
|
1st day
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- REC-FSD-00245
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Low Back Pain
-
Dow University of Health SciencesRecruitingLow Back Pain | Chronic Low-back Pain | Low Back Pain, Mechanical | Mechanical Low Back Pain | Pain, Chronic | Pain, Back | Lower Back Pain Chronic | CLBP - Chronic Low Back PainPakistan
-
Faculdade de Ciências Médicas da Santa Casa de...CompletedLow Back Pain, Mechanical | Low Back Pain, Postural | Lower Back Pain Chronic | Low Back Pain, Posterior CompartmentBrazil
-
University School of Physical Education in WroclawCompletedLow Back Pain | Low Back Pain, Mechanical | Low Back Pain, PosturalPoland
-
Texas Woman's UniversityTexas Physical Therapy AssociationCompletedLow Back Pain | Chronic Low Back Pain | Subacute Low Back PainUnited States
-
University of ParmaKing's College London; Helmholtz Zentrum München; GENOS; Ip Research Consulting... and other collaboratorsUnknownChronic Low Back Pain | Acute Low Back PainUnited States, Australia, Belgium, Croatia, Italy, United Kingdom
-
Ache Laboratorios Farmaceuticos S.A.Unknown
-
Palmer College of ChiropracticDepartment of Health and Human ServicesCompletedChronic Low Back Pain | Subacute Low Back PainUnited States
-
Universität Duisburg-EssenSiemens-BetriebskrankenkasseCompletedChronic Low Back Pain | Recurrent Low Back Pain
-
Karolinska InstitutetCompletedChronic Low Back Pain | Recurrent Low Back Pain | Persistent Low Back PainSweden
-
Apsen Farmaceutica S.A.CompletedLow Back Pain | Low Back Pain, Mechanical | Acute Low Back PainBrazil